On June 11, 2025 BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, reported that it will host an Investor R&D Day in New York City and via webcast on June 26, 2025 at 8:30 am ET (Press release, BeOne Medicines, JUN 11, 2025, View Source [SID1234653828]). John V. Oyler, Co-Founder, Chairman, and CEO of BeOne, along with the Company’s leadership team and distinguished key opinion leaders, will provide an update on BeOne’s extensive global innovation pipeline and platforms, including new assets, targets and clinical data, and will share insights on the Company’s vision, differentiated capabilities, and value creation drivers.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Live webcast of this event can be accessed from the investors section of the Company’s website at View Source, View Source beonemedicines.com/, View Source beonemedicines.com/. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the Company’s website.